Refolding of ScFv-CBD fusion protein from Escherichia coli inclusion bodies

O. B. Gorbatuk(National Academy of Sciences of Ukraine), Pavlo Gilchuk(AstraZeneca (Japan)), Д. М. Іродов(National Academy of Sciences of Ukraine), U. S. Nikolayev(National Academy of Sciences of Ukraine), I. Ya. Dubey(National Academy of Sciences of Ukraine)
Biopolymers and Cell
January 20, 2008
10.7124/bc.000790
Cited by 4

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
|Cell|2021|409